5.edited (6).edited (1)

docx

School

LICCS Group of Colleges, Layyah *

*We aren’t endorsed by this school

Course

222

Subject

Economics

Date

Nov 24, 2024

Type

docx

Pages

5

Uploaded by CaptainSnow797

Report
Tylenol Recall Student’s Name Course Professor’s Name Institution Date
Tylenol Recall Companies and organizations frequently experience crises as a result of carelessness or miscalculation. Tylenol is a well-known over-the-counter painkiller that is used globally. However, a crisis changed how product security and safety were viewed as a whole. Before the crisis, this analgesic held a 37 percent market share, fostering the growth and development of the world economy ( Rockoff & Loftus, 2021) . The company has seen some setbacks during its existence, including the recall of some of its products owing to contamination. The paper focuses on one of the earlier Tylenol recalls and looks at how it raised safety standards in the sector. It also focuses on the background and development of the legal system that governs medical packaging. Tylenol Recall In 1982, Tylenol's parent company, Johnson & Johnson, encountered a serious crisis. This resulted in several people in Chicago dying after taking Tylenol capsules laced with cyanide. Thirty-one million bottles of Tylenol were recalled as a result of the incident, at a cost to the corporation of almost $100 million (Argenti, 2020). The public was first made aware of the risks of taking Tylenol by Johnson & Johnson and the media. The announcement caused widespread dread and concern among the populace, which was a significant turning point for the business. The recall highlighted the importance of product safety and security despite being a significant setback for the company. Evolvement of Medical Packaging Johnson & Johnson promptly implemented tamper-resistant packaging for all its products in response to the problem. This included introducing tamper-evident seals, which made it easy
to detect if the packaging had been opened or tampered with ( Rockoff & Loftus 2021) . The debut of this packaging established a new benchmark for the pharmaceutical sector, and other businesses quickly followed suit. The medical packaging sector has developed tremendously since the Tylenol recall in 1982. All over-the-counter and prescription pharmaceuticals now come in tamper-evident packaging as a standard feature (Argenti, 2020). The Food and Drug Administration (FDA) also establishes tough rules and guidelines to promote consumer safety. The Poison Prevention Packaging Act of 1970 is one such legislation that mandates that all pharmaceuticals and household items be packed in child-resistant cans. The medical packaging sector has not been an exception to the growing trend toward sustainable packaging in recent years. Currently, businesses are concentrating on minimizing the environmental effects of their packaging while maintaining the quality of their goods. Smart packaging, which can deliver real- time information on the product, such as its expiration date and usage instructions, has been made possible due to technological improvements. Other Recalls Several major recalls involving medical packaging have resulted in the recent past. Over $135 million bottles of Tylenol, Motrin, and other pharmaceuticals were recalled in 2010 by McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, because of problems with quality control. The incident brought attention to the necessity of upholding strict quality control standards and prompted many improvements in the sector. In conclusion, the 1982 Tylenol recall was a noteworthy occurrence that underlined the importance of preserving product safety and security. Some significant advancements in medical packaging, like tamper-evident packaging and child-resistant packaging, were made as a result of the crisis. These innovations have considerably improved the safety of over-the-counter
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
medications and established standards for the sector to safeguard consumers from harm. As the sector develops and changes, it is crucial to maintain strict quality control and safety requirements.
References Argenti, P. A. (2020). Communicating through the coronavirus crisis. Harvard Business Review , 13 . Rockoff, J. D., & Loftus, P. (2021). Johnson & Johnson to Split Consumer From Pharmaceutical, Medical-Device Businesses, Creating Two Companies; Consumer business—home to Band-Aid and Tylenol—will be shed within 24 months. The Wall Street Journal. Eastern Edition